<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>clinical-trials | The Miller Lab</title>
    <link>/tags/clinical-trials/</link>
      <atom:link href="/tags/clinical-trials/index.xml" rel="self" type="application/rss+xml" />
    <description>clinical-trials</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Thu, 28 Nov 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/img/TML-logo.png</url>
      <title>clinical-trials</title>
      <link>/tags/clinical-trials/</link>
    </image>
    
    <item>
      <title>Clinical Trials for Skin Cancer</title>
      <link>/project/clinical-trials/</link>
      <pubDate>Thu, 28 Nov 2019 00:00:00 +0000</pubDate>
      <guid>/project/clinical-trials/</guid>
      <description>

&lt;h1 id=&#34;overview&#34;&gt;Overview&lt;/h1&gt;

&lt;p&gt;We are involved with clinical studies to improve outcomes for patients with Skin Cancer&lt;/p&gt;

&lt;h1 id=&#34;clinical-trials-in-merkel-cell-carcinoma&#34;&gt;Clinical Trials in Merkel Cell Carcinoma&lt;/h1&gt;

&lt;p&gt;Dr. Miller is the MGH site Principal Investigator for &lt;a href=&#34;https://clinicaltrials.gov/ct2/show/NCT03712605?term=pembrolizumab&amp;amp;cond=merkel+cell+carcinoma&amp;amp;draw=2&amp;amp;rank=5&#34; target=&#34;_blank&#34;&gt;STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial&lt;/a&gt;&lt;/p&gt;

&lt;h1 id=&#34;clinical-trials-in-melanoma&#34;&gt;Clinical Trials in Melanoma&lt;/h1&gt;

&lt;p&gt;Dr. Miller is a MGH sub-investigator for &lt;a href=&#34;https://clinicaltrials.gov/ct2/show/NCT03272464?term=flaherty&amp;amp;cond=melanoma&amp;amp;draw=2&amp;amp;rank=1&#34; target=&#34;_blank&#34;&gt;INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
